Fatal Kawasaki disease caused by early occlusive coronary artery disease

Area of Science:

• Pediatric Cardiology
• Rheumatology
• Immunology

Background:

• Kawasaki disease is a leading cause of acquired heart disease in children.
• Early diagnosis and treatment are crucial to prevent coronary artery abnormalities.
• Gammaglobulin therapy is the standard treatment to reduce inflammation.

Observation:

• Severe coronary artery narrowing can manifest early in Kawasaki disease.
• This narrowing can occur despite standard gammaglobulin treatment.
• Aneurysm formation or thrombosis may not be prominent features initially.

Findings:

• Vaso-occlusive disease in Kawasaki disease may not be clinically apparent until it reaches a severe stage.
• Echocardiography might not reveal subtle or early-stage vaso-occlusive changes.
• Coronary artery narrowing can progress significantly before detection.

Implications:

• There is a need for heightened vigilance for coronary artery complications in Kawasaki disease, irrespective of initial treatment response.
• Advanced imaging or monitoring techniques may be required for early detection of vaso-occlusive disease.
• Understanding the early pathophysiology of coronary narrowing is vital for improved therapeutic strategies.